In addition to conventional thrombophilias (Factor V Leiden mutation; prothrombin 20210A mutation; PC, PS, and AT III deficiencies; lupus anticoagulant; and anticardiolipin antibodies), novel thrombophilias have been recently investigated and also appear to potentially affect pregnancy outcomes [15]. The gene discussed is F5; the disease is Rare hereditary thrombophilia.